Cargando…

Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism

BACKGROUND: Venous thromboembolism (VTE) and thromboembolic arterial diseases are usually considered to be distinct entities, but there is evidence to suggest that these disorders may be linked. The aim of this study was to determine whether a diagnosis of VTE increases the long-term risk of myocard...

Descripción completa

Detalles Bibliográficos
Autores principales: Huerta, Consuelo, Johansson, Saga, Wallander, Mari-Ann, Rodríguez, Luis A García
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2531082/
https://www.ncbi.nlm.nih.gov/pubmed/18706117
http://dx.doi.org/10.1186/1477-9560-6-10
_version_ 1782158961776001024
author Huerta, Consuelo
Johansson, Saga
Wallander, Mari-Ann
Rodríguez, Luis A García
author_facet Huerta, Consuelo
Johansson, Saga
Wallander, Mari-Ann
Rodríguez, Luis A García
author_sort Huerta, Consuelo
collection PubMed
description BACKGROUND: Venous thromboembolism (VTE) and thromboembolic arterial diseases are usually considered to be distinct entities, but there is evidence to suggest that these disorders may be linked. The aim of this study was to determine whether a diagnosis of VTE increases the long-term risk of myocardial infarction (MI). METHODS: The incidence rate (IR) and relative risk (RR) of MI in a cohort of patients with a diagnosis of VTE (n = 4890) compared with that of a control cohort without prior VTE (n = 43 382) were evaluated in the UK General Practice Research Database (GPRD). Death during follow-up was also determined. Patients were followed for up to 8 years (mean of 3 years). RESULTS: The IR of MI per 1000 person-years was 4.1 (95% CI: 3.1–5.3) for the VTE cohort and 3.5 (95% CI: 3.2–3.8) for the control cohort. The IR of MI was highest in the first year after the VTE episode, but overall differences between the two cohorts were not significant (RR of MI associated with VTE: 1.2; 95% CI: 0.9–1.6). The risk of death was higher in the VTE cohort than the control cohort, even after adjustment for cancer, heart failure and ischaemic heart disease (RR: 2.4; 95% CI: 2.2–2.6), particularly during the first year after VTE (RR: 3.8; 95% CI: 3.4–4.3). CONCLUSION: A VTE episode does not significantly increase the risk of MI, but does increase the risk of death, particularly in the first year following VTE diagnosis.
format Text
id pubmed-2531082
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25310822008-09-06 Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism Huerta, Consuelo Johansson, Saga Wallander, Mari-Ann Rodríguez, Luis A García Thromb J Original Clinical Investigation BACKGROUND: Venous thromboembolism (VTE) and thromboembolic arterial diseases are usually considered to be distinct entities, but there is evidence to suggest that these disorders may be linked. The aim of this study was to determine whether a diagnosis of VTE increases the long-term risk of myocardial infarction (MI). METHODS: The incidence rate (IR) and relative risk (RR) of MI in a cohort of patients with a diagnosis of VTE (n = 4890) compared with that of a control cohort without prior VTE (n = 43 382) were evaluated in the UK General Practice Research Database (GPRD). Death during follow-up was also determined. Patients were followed for up to 8 years (mean of 3 years). RESULTS: The IR of MI per 1000 person-years was 4.1 (95% CI: 3.1–5.3) for the VTE cohort and 3.5 (95% CI: 3.2–3.8) for the control cohort. The IR of MI was highest in the first year after the VTE episode, but overall differences between the two cohorts were not significant (RR of MI associated with VTE: 1.2; 95% CI: 0.9–1.6). The risk of death was higher in the VTE cohort than the control cohort, even after adjustment for cancer, heart failure and ischaemic heart disease (RR: 2.4; 95% CI: 2.2–2.6), particularly during the first year after VTE (RR: 3.8; 95% CI: 3.4–4.3). CONCLUSION: A VTE episode does not significantly increase the risk of MI, but does increase the risk of death, particularly in the first year following VTE diagnosis. BioMed Central 2008-08-18 /pmc/articles/PMC2531082/ /pubmed/18706117 http://dx.doi.org/10.1186/1477-9560-6-10 Text en Copyright © 2008 Huerta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Clinical Investigation
Huerta, Consuelo
Johansson, Saga
Wallander, Mari-Ann
Rodríguez, Luis A García
Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism
title Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism
title_full Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism
title_fullStr Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism
title_full_unstemmed Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism
title_short Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism
title_sort risk of myocardial infarction and overall mortality in survivors of venous thromboembolism
topic Original Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2531082/
https://www.ncbi.nlm.nih.gov/pubmed/18706117
http://dx.doi.org/10.1186/1477-9560-6-10
work_keys_str_mv AT huertaconsuelo riskofmyocardialinfarctionandoverallmortalityinsurvivorsofvenousthromboembolism
AT johanssonsaga riskofmyocardialinfarctionandoverallmortalityinsurvivorsofvenousthromboembolism
AT wallandermariann riskofmyocardialinfarctionandoverallmortalityinsurvivorsofvenousthromboembolism
AT rodriguezluisagarcia riskofmyocardialinfarctionandoverallmortalityinsurvivorsofvenousthromboembolism